Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 50.50
-1.10 (-2.13%)
Mar 4, 2026, 9:19 AM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.49 billion as of March 3, 2026. Its market cap has increased by 235.18% in one year.
Market Cap
3.49B
Enterprise Value
2.67B
Revenue
424.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.50
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.49B, an increase of 1,107.31%. That is a compound annual growth rate of 13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.48B | 0.39% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.21B |
| Formosa Pharmaceuticals | 4.20B |
| Intech Biopharm | 4.08B |
| ACRO Biomedical | 3.89B |
| BRIM Biotechnology | 3.62B |
| Genovate Biotechnology | 3.62B |
| Shine-On BioMedical | 3.34B |
| Syngen Biotech | 3.25B |